pentixapharm.com
Aktiengesellschaft
Pentixapharm is a radiopharmaceutical development company founded in 2019, with its headquarters in Würzburg, Germany. It is committed to develop the innovative theranostic pair PentixaFor and PentixaTher, two small peptide-based radiopharmaceuticals that specifically target the CXCR4-receptor.
last observed
Activity Score
0
confidence 85 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 55 % · cci-v1
8 active sensors·7 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-14
Compare pentixapharm.com with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
